Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions
Healthy
Interventions
DRUG

Intranasal insulin

"Enrolled Participants for this trial will come for 3 study visits. The doses will be administered in varying order: participants will be randomized to one six possible permutations of the intranasal study doses (0, 500, 1000 U) of intranasal insulin at each visit.~Participants will undergo a fMRI scan before and after receiving intranasal doses. Additionally, participants will have blood samples taken."

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

Florian Schmitzberger

OTHER

NCT06144255 - Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI) | Biotech Hunter | Biotech Hunter